FDA Clearance Tracker · K250893
Ball Joint Guide Array (66295)
Last checked: Nov 19, 2026Latest source record: Sep 4, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Sep 4, 2025
Substantially Equivalent
Time to decision
163 days
Received Mar 25, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K250893
- Device name
- Ball Joint Guide Array (66295)
- Applicant
- Bayer Medical Care, Inc.
- Applicant location
- Indianaola, PA
- Received
- Mar 25, 2025
- Decided
- Sep 4, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Neurological Stereotaxic Instrument (HAW)
- Device class
- Class II
- Regulation
- 21 CFR 882.4560
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code HAW. The earliest in FDA's data is K790502, decided Apr 5, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250893
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bayer Medical Care, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262043 · Decided Oct 6, 2026 · 111 days after receipt
Device type: Injector And Syringe, Angiographic (DXT) · Cardiology
K253688 · Decided Jun 12, 2026 · 203 days after receipt
Device type: Iodinated Contrast Media Transfer Tubing Set (PQH) · Hospital Medicine & Nursing
- MEDRAD MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD ISI2 Module (ISI2)510(k)
K252891 · Decided Feb 13, 2026 · 155 days after receipt
Device type: Injector And Syringe, Angiographic (DXT) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.